Recent Activity

Loading...

CNCR

Range Cancer Therapeutics ETF · NAS

  • Category Equity
  • Expense Ratio 0.79%
  • Listing Date Oct 14, 2015
  • Volume 961.0
  • Market Cap (AUM) $18.65M

Performance

+5.06%

1W

+0.57%

1M

+4.22%

3M

+51.31%

6M

+17.22%

YTD

+16.19%

1Y

Top Holdings

  • Name
    Symbol
    %Assets
  • Geron CorporationGERN3.05%
  • ImmunityBio IncIBRX2.27%
  • Cullinan Therapeutics, Inc.CGEM2.17%
  • Acrivon Therapeutics, Inc.ACRV2.12%
  • Deciphera Pharmaceuticals, Inc.DCPH2.08%
  • Enliven Therapeutics, Inc.ELVN2.05%
  • Janux Therapeutics, Inc.JANX2.01%
  • Nuvation Bio, Inc. Class ANUVB1.91%
  • Day One Biopharmaceuticals, Inc.DAWN1.63%
  • Revolution Medicines, Inc.RVMD1.59%

Technical Analysis of CNCR 2024-05-03

Overview:

In analyzing the technical indicators for CNCR over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days.

Trend Analysis:

  • Moving Averages (MA): The 5-day Moving Average has been consistently above the Simple...
See more ...

Recent News & Updates